Policy & Regulation
Aldeyra Therapeutics Raises USD 74.7m from Common Stock Offering
20 January 2021 - - US-based biotechnology company Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) has closed its underwritten public offering of 7,868,421 shares of its common stock at a public offering pr...
Stem Cell and Research Therapy Publishes Preclinical Data Highlighting the Potential of a NurOwn Derived Exosome-Based Treatment for COVID-19 ARDS
20 January 2021 - - US-based adult stem cell therapies developer BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI) is highlighting the peer-reviewed publication of a preclinical study in the ...
US FDA Accepts for Priority Review Application for Opdivo Combined with Chemotherapy as First-Line Treatment in Metastatic Gastric Cancer, Gastroesophageal Junction Cancer and Esophageal Adenocarcinoma
20 January 2021 - - The US Food and Drug Administration has accepted its supplemental Biologics License Application for Opdivo (nivolumab), in combination with fluoropyrimidine- and platinum...
First Patient Dosed in Phase 1 Clinical Trial Evaluating FT-7051 for the Treatment of Metastatic Castration-resistant Prostate Cancer
20 January 2021 - - The first patient has been dosed in a Phase 1 clinical trial evaluating FT-7051, a selective inhibitor of CBP/p300, a known co-activator of the androgen receptor in men with metast...
Aveo Oncology Receives Commitment for an Incremental USD 10m Loan in Addition to Current Tranched, USD 35m Debt Facility with Hercules Capital
20 January 2021 - - US-based Aveo Oncology (NASDAQ: AVEO) has received a commitment letter for an incremental USD 10m loan from Hercules Capital, Inc. (NYSE: HTGC) and its affiliates, to be added to t...
UK to help Kenya prepare for roll-out of AstraZeneca/ Oxford COVID-19 vaccine
20 January 2021 - UK foreign secretary Dominic Raab has stated that the UK is assisting Kenya to prepare for the roll-out of a COVID-19 vaccine developed by British pharmaceutical company Astrazeneca ...